Krsnaa Diagnostics wins order from Municipal Corporation of Delhi (MCD), through its Department of Hospital…
Krsnaa Diagnostics (KRSNAA) said it has received an order from Municipal Corporation of Delhi (MCD), through its Department of Hospital Administration.. The company is valued at about ₹1,560 crore.
What happened
Krsnaa Diagnostics (KRSNAA) told the exchanges on 3 November 2026 at 02:35 PM that it has received an order from Municipal Corporation of Delhi (MCD), through its Department of Hospital Administration..
From the filing: "The award has been made for a concession period of ten years from the Commercial Operation Date, extendable by upto five years as per the Tender D ocument."
Company snapshot
Krsnaa Diagnostics is a small-cap company, with a market value of about ₹1,560 crore.
The stock last traded at ₹481.1, against a 52-week range of ₹463.1–₹838 (42.6% below the high).
Before this filing the shares had moved −10.9% over the month and −7.8% over three months. Average daily turnover over the last 20 sessions was about ₹3.16 crore.
Promoters held 27.11% at the end of Q2 FY27. Foreign institutions owned 3.84% and domestic institutions 14.50%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q2 FY26 | 206 | 23.9 | 7.38 |
| Q3 FY26 | 181 | 15.2 | 4.72 |
| Q4 FY26 | 193 | 41.7 | 12.86 |
| Q1 FY27 | 236 | 16.6 | 5.1 |
| Q2 FY27 | 271 | 24.6 | 7.64 |
What history shows
This is not the company's first order win disclosure: BCEIE has 1 earlier filing of this kind on record since May 2026.
Market-wide, 2,114 order win filings with an impact score of 50 or more saw an average next-day move of +0.8%, with 53% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Execution progress and revenue recognition from this order in the coming quarters.
In the news
Recent coverage elsewhere (links open the original publisher):
- Krsnaa Diagnostics Limited (KRSNAA.NS) Seasonal returns chart
- Krsnaa Diagnostics Q2 2027 Earnings Call Is Live
- Earnings call transcript: Krsnaa Diagnostics posts record Q2 2026 revenue, shares fall By Investing.com
- Krsnaa Diagnostics Ties Up With AZmed to Test AI Fracture Triage Across Its 5-Million-a-Year X-ray Network
- Krsnaa Diagnostics announces strategic collaboration with global radiology AI innovator; shares open in red
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.